Sponsored by North American Center for Continuing Medical Education (NACCME)
Presenters
Lee C. Rogers, DPM
Director,
Amputation Prevention Center at
Broadlawns Medical Center
Des Moines, Iowa
Jason Hanft, DPM, FACFAS
Director of Podiatric Medical Education
South Miami Hospital/Baptist Health System
Foot And Ankle Institute
South Miami, Florida
Robert G. Frykberg, DPM, MPH, FACFAS
Chief, Podiatric Medicine and Surgery
Carl T. Hayden VA Medical Center
Past President
American College of Foot And Ankle Surgeons
Phoenix, Arizona
Target Audience
This activity is designed for podiatrists, general surgeons, vascular surgeons, geriatric/internal medicine physicians and orthopedic surgeons.
Learning Objectives
After completing this activity, participants should be able to:
- Discuss the increasing prevalence of diabetes
- Review current statistics on the complications of foot ulceration and lower extremity amputation in patients with diabetes
- Review key principles such as infection control, debridement, facilitating granulation tissue and offloading in patients with diabetic foot ulcers
- Determine when one should consider the use of advanced therapies for chronic DFUs
- Explain the mechanism of negative pressure wound therapy as an adjunctive modality for DFUs
- Describe the findings from studies on the use of bioengineered skin substitutes for diabetic foot ulcerations
- Cite the current indications, contraindications and potential side effects for bioengineered skin substitutes
- Assess the findings from studies on the uses of an allogenic matrix therapy, a dermal regeneration template and acellular dermal regeneration matrix to help facilitate healing of DFUs
- Review the potential pros and cons of allogenic matrix therapy, a dermal regeneration template and acellular dermal regeneration matrix for DFUs
Activity Overview
This on-demand video webcast is available with synchronized slides, audio, and video.
To be eligible for documentation of credit, participants must attend the full activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit.
For questions regarding this educational activity, please contact Angela Scarnici at 609-371-1137
There is no fee associated with this activity.
Hardware/Software Requirements
All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.
Release Date: January 20, 2009
Expiration Date: January 20, 2010
Estimated time to complete: 1 hour
CME Accreditation
This activity is sponsored by North American Center for Continuing Medical Education (NACCME). NACCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CPME Accreditation
NACCME is approved by the Council on Podiatric Medical Education as a sponsor of continuing education in podiatric medicine. This program is approved for 1 continuing education contact hours.
Independent Clinical Reviewer
David G. Armstrong, DPM, PhD
Professor of Surgery
Director, Southern Arizona Limb Salvage Alliance (SALSA)
University of Arizona College of Medicine
Tucson, Arizona
Planning Committee
The planning committee comprises Lee Rogers, DPM, Jason Hanft, DPM, Robert Frykberg, DPM; Trish Levy, NACCME and Jeff Hall, HMP Communications.
Financial Disclosure and Conflicts of Interest
According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The faculty has reported the following:
Dr. Frykberg has disclosed that he has received grant/research support from Regenesis Biomedical, Sanuwave, KCI, Dermasciences, Oculus, Organogenesis, Advanced Biohealing, Wound Solutions, PamLabs, Silverleaf and Hypermed. He is a scientific advisor to Regenesis Biomedical, Hypermed and Oculus. He is a member of the speaker’s bureau for Pfizer, Organogenesis, KCI, Advanced BioHealing, Inc. Hypermed and Derma Sciences.
Dr. Hanft has disclosed that he has received grant/research support from Intercytex. He is a consultant to AlloSource and he is a member of the speakers’ bureau for Advanced BioHealing
Dr. Rogers has disclosed that he has received grant/research support from Small Bone Innovations and Smith & Nephew. He is a scientific advisor to Smith & Nephew. He is a member of the speakers’ bureau for Smith& Nephew, Pfizer, Advanced BioHealing, Molnlycke and Small Bone Innovations.
Clinical Reviewer: Dr. Armstrong has disclosed that he has no relevant financial relationships with any commercial interest.
Planning Committee: T. Levy, NACCME and J. Hall, HMP Communications have disclosed that they have no relevant financial relationship with any commercial interest.
NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.
The faculty has disclosed the following off-label/unapproved use(s) of drugs and/or devices will be discussed: The use of skin equivalents the treatment of diabetic wounds.
Privacy Policy
NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
NACCME maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2009 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from the North American Center for Continuing Medical Education.
Grant Support
Supported by an educational grant from Advanced BioHealing, Inc
Representatives of the granting organization may not register on behalf of participants.
